EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer

Khanis Farhana Tuly, Md Bayazid Hossen iD, Md Ariful Islam iD, Md Kaderi Kibria iD, Md Shahin Alam, Md Harun-Or-Roshid iD, Anjuman Ara Begum, Sohel Hasan, Rashidul Alam Mahumud, Md Nurul Haque Mollah iD

Medicina · 2023

DOI: 10.3390/medicina59101705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, 2023. Verfasst von Khanis Farhana Tuly und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi 6205, Bangladesh. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rajshahi University Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Breast cancer (BC) is one of the major causes of cancer-related death in women globally. Proper identification of BC-causing hub genes (HubGs) for prognosis, diagnosis, and therapies at an earlier stage may reduce such death rates. However, most of the previous studies detected HubGs through non-robust statistical approaches that are sensitive to outlying observations. Therefore, the main objectives of this study were to explore BC-causing potential HubGs from robustness viewpoints, highlighting their early prognostic, diagnostic, and therapeutic performance. Materials and Methods: Integrated robust statistics and bioinformatics methods and databases were used to obtain the required results.

Results

We robustly identified 46 common differentially expressed genes (cDEGs) between BC and control samples from three microarrays (GSE26910, GSE42568, and GSE65194) and one scRNA-seq (GSE235168) dataset. Then, we identified eight cDEGs (COL11A1, COL10A1, CD36, ACACB, CD24, PLK1, UBE2C, and PDK4) as the BC-causing HubGs by the protein-protein interaction (PPI) network analysis of cDEGs. The performance of BC and survival probability prediction models with the expressions of HubGs from two independent datasets (GSE45827 and GSE54002) and the TCGA (The Cancer Genome Atlas) database showed that our proposed HubGs might be considered as diagnostic and prognostic biomarkers, where two genes, COL11A1 and CD24, exhibit better performance. The expression analysis of HubGs by Box plots with the TCGA database in different stages of BC progression indicated their early diagnosis and prognosis ability. The HubGs set enrichment analysis with GO (Gene ontology) terms and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways disclosed some BC-causing biological processes, molecular functions, and pathways. Finally, we suggested the top-ranked six drug molecules (Suramin, Rifaximin, Telmisartan, Tukysa Tucatinib, Lynparza Olaparib, and TG.02) for the treatment of BC by molecular docking analysis with the proposed HubGs-mediated receptors. Molecular docking analysis results also showed that these drug molecules may inhibit cancer-related post-translational modification (PTM) sites (Succinylation, phosphorylation, and ubiquitination) of hub proteins.

Conclusions

This study’s findings might be valuable resources for diagnosis, prognosis, and therapies at an earlier stage of BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleTranscriptomeMolecular Docking SimulationBiomarkers, TumorEarly Detection of CancerGene Expression ProfilingPrognosisGene Expression Regulation, NeoplasticGene Regulatory Networks

Stichwörter der Autor:innen

breast cancerearly diagnosishub-genesintegrated robust statistics and bioinformatics approachesprognosis and therapiestranscriptomics profiles

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Bioinformatics Lab, Department of Statistics, University of Rajshahi, Rajshahi 6205, Bangladesh.
  • Department of Statistics, Hajee Mohammad Danesh Science & Technology University, Dinajpur 5200, Bangladesh.
  • Molecular and Biomedical Health Science Lab, Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi 6205, Bangladesh.
  • NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.

ORCID-Profile: Md Bayazid Hossen, Md Ariful Islam, Md Kaderi Kibria, Md Harun-Or-Roshid, Md Nurul Haque Mollah

Förderung

  • Rajshahi University Research Project

Zitieren

APA

Tuly, K. F., Hossen, M. B., Islam, M. A., Kibria, M. K., Alam, M. S., Harun-Or-Roshid, M., Begum, A. A., Hasan, S., Mahumud, R. A., & Mollah, M. N. H. (2023). Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer. Medicina. https://doi.org/10.3390/medicina59101705

Vancouver

Tuly KF, Hossen MB, Islam MA, Kibria MK, Alam MS, Harun-Or-Roshid M, et al. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer. Medicina. 2023. doi:10.3390/medicina59101705

BibTeX
@article{Tuly2023,
  author = {Tuly, Khanis Farhana and Hossen, Md Bayazid and Islam, Md Ariful and Kibria, Md Kaderi and Alam, Md Shahin and Harun-Or-Roshid, Md and Begum, Anjuman Ara and Hasan, Sohel and Mahumud, Rashidul Alam and Mollah, Md Nurul Haque},
  title = {Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer},
  journal = {Medicina},
  year = {2023},
  doi = {10.3390/medicina59101705}
}
Kostenlos starten →